This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halpern, J L
Right arrow Articles by Stibitz, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halpern, J L
Right arrow Articles by Stibitz, S

 Previous Article  |  Next Article 

Infect Immun. 1990 April; 58(4): 1004-1009

Cloning and expression of functional fragment C of tetanus toxin.

J L Halpern, W H Habig, E A Neale and S Stibitz

Division of Bacterial Products, Food and Drug Administration, Bethesda, Maryland.

ABSTRACT

A segment of Clostridium tetani DNA corresponding to fragment C of tetanus toxin was amplified by using the polymerase chain reaction. This fragment was cloned into expression vector pTTQ8, under the control of the tac promoter. Expression of this plasmid in Escherichia coli resulted in the production of a protein consisting of 8 amino acids of the vector fused to the C-terminal 460 amino acids of tetanus toxin. This protein (rFragment C) was recognized by an antipeptide antibody specific for fragment C in an enzyme-linked immunosorbent assay and on immunoblots. rFragment C could be purified significantly in one step by immunoaffinity chromatography. Immunization of mice with rFragment C resulted in the production of antibodies that were able to protect the mice against a challenge with tetanus toxin. rFragment C bound to ganglioside GT1b and to neuronal cells in a manner indistinguishable from that of fragment C obtained by papain cleavage of tetanus toxin. For many applications, rFragment C appears to be a suitable alternative to tetanus toxin or toxin-derived fragment C.


Infect Immun. 1990 April; 58(4): 1004-1009




This article has been cited by other articles:

  • Leitner, W. W., Baker, M. C., Berenberg, T. L., Lu, M. C., Yannie, P. J., Udey, M. C. (2009). Enhancement of DNA tumor vaccine efficacy by gene gun-mediated codelivery of threshold amounts of plasmid-encoded helper antigen. Blood 113: 37-45 [Abstract] [Full Text]  
  • Mesnage, S., Weber-Levy, M., Haustant, M., Mock, M., Fouet, A. (1999). Cell Surface-Exposed Tetanus Toxin Fragment C Produced by Recombinant Bacillus anthracis Protects against Tetanus Toxin. Infect. Immun. 67: 4847-4850 [Abstract] [Full Text]  
  • Lalli, G, Herreros, J, Osborne, S., Montecucco, C, Rossetto, O, Schiavo, G (1999). Functional characterisation of tetanus and botulinum neurotoxins binding domains. J. Cell Sci. 112: 2715-2724 [Abstract]  
  • Francis, J. W., Sandrock, A. W., Bhide, P. G., Vonsattel, J.-P., Brown, R. H. Jr. (1998). Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues. Proc. Natl. Acad. Sci. USA 95: 6492-6497 [Abstract] [Full Text]  
  • Coen, L., Osta, R., Maury, M., Brulet, P. (1997). Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system. Proc. Natl. Acad. Sci. USA 94: 9400-9405 [Abstract] [Full Text]  
  • Francis, J. W., Hosler, B. A., Brown, R. H. Jr., Fishman, P. S. (1995). CuZn Superoxide Dismutase (SOD-1):Tetanus Toxin Fragment C Hybrid Protein for Targeted Delivery of SOD-1 to Neuronal Cells. J. Biol. Chem. 270: 15434-15442 [Abstract] [Full Text]